Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
7 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Thalidomide, dexamethasone, and pegylated liposomal doxorubicin (ThaDD) for patients older than 65 years with newly diagnosed multiple myeloma.
Blood. 2006 Oct 1;108(7):2159-64. doi: 10.1182/blood-2006-03-013086. Epub 2006 Jun 8.
Blood. 2006.
PMID: 16763209
Free article.
Clinical Trial.
Low-dose thalidomide with pegylated liposomal doxorubicin and high-dose dexamethasone for relapsed/refractory multiple myeloma: a prospective, multicenter, phase II study.
Offidani M, Corvatta L, Marconi M, Visani G, Alesiani F, Brunori M, Galieni P, Catarini M, Burattini M, Centurioni R, Rupoli S, Scortechini AR, Giuliodori L, Candela M, Capelli D, Montanari M, Olivieri A, Piersantelli MN, Leoni P.
Offidani M, et al. Among authors: piersantelli mn.
Haematologica. 2006 Jan;91(1):133-6.
Haematologica. 2006.
PMID: 16434383
Clinical Trial.
Item in Clipboard
Thalidomide-dexamethasone plus pegylated liposomal doxorubicin vs. thalidomide-dexamethasone: a case-matched study in advanced multiple myeloma.
Offidani M, Bringhen S, Corvatta L, Falco P, Marconi M, Avonto I, Piersantelli MN, Polloni C, Boccadoro M, Leoni P, Palumbo A.
Offidani M, et al. Among authors: piersantelli mn.
Eur J Haematol. 2007 Apr;78(4):297-302. doi: 10.1111/j.1600-0609.2007.00823.x. Epub 2007 Feb 5.
Eur J Haematol. 2007.
PMID: 17286608
Item in Clipboard
Serum C-reactive protein at diagnosis and response to therapy is the most powerful factor predicting outcome of multiple myeloma treated with thalidomide/ anthracycline-based therapy.
Offidani M, Corvatta L, Polloni C, Piersantelli MN, Galieni P, Visani G, Alesiani F, Catarini M, Brunori M, Burattini M, Centurioni R, Ferranti M, Giuliodori L, Candela M, Mele A, Marconi M, Leoni P.
Offidani M, et al. Among authors: piersantelli mn.
Clin Lymphoma Myeloma. 2008 Oct;8(5):294-9. doi: 10.3816/CLM.2008.n.041.
Clin Lymphoma Myeloma. 2008.
PMID: 18854284
Item in Clipboard
Thalidomide-dexamethasone versus interferon-alpha-dexamethasone as maintenance treatment after ThaDD induction for multiple myeloma: a prospective, multicentre, randomised study.
Offidani M, Corvatta L, Polloni C, Piersantelli MN, Gentili S, Galieni P, Visani G, Alesiani F, Catarini M, Brunori M, Samori A, Burattini M, Centurioni R, Ferranti M, Giuliodori L, Candela M, Mele A, Marconi M, Leoni P.
Offidani M, et al. Among authors: piersantelli mn.
Br J Haematol. 2009 Mar;144(5):653-9. doi: 10.1111/j.1365-2141.2008.07495.x. Epub 2008 Nov 13.
Br J Haematol. 2009.
PMID: 19036082
Free article.
Clinical Trial.
Item in Clipboard
Diagnostic value of C-reactive protein in discriminating fungal from nonfungal pulmonary infiltrates in patients with hematologic malignancies.
Offidani M, Corvatta L, Malerba L, Piersantelli MN, Manso E, Leoni P.
Offidani M, et al. Among authors: piersantelli mn.
Support Care Cancer. 2006 Aug;14(8):874-7. doi: 10.1007/s00520-006-0030-0. Epub 2006 Feb 15.
Support Care Cancer. 2006.
PMID: 16479314
Item in Clipboard
The Prognostic Role of Procalcitonin in Critically Ill Patients Admitted in a Medical Stepdown Unit: A Retrospective Cohort Study.
Zaccone V, Falsetti L, Nitti C, Gentili T, Marchetti A, Piersantelli MN, Sampaolesi M, Riccomi F, Raponi A, Salvi A.
Zaccone V, et al. Among authors: piersantelli mn.
Sci Rep. 2020 Mar 11;10(1):4531. doi: 10.1038/s41598-020-61457-6.
Sci Rep. 2020.
PMID: 32161314
Free PMC article.
Clinical Trial.
Item in Clipboard
Cite
Cite